Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiac Biotech Solutions, Inc. (formerly CB Scientific, Inc.) is a medical technology company focused on the design, manufacture, and distribution of non-invasive ambulatory cardiac monitoring products and services. The company's core technology includes its flagship MyCardia AT and CardioHolter AT devices, which utilize interactive cloud-based acquisition software and mobile applications to help physicians detect and manage abnormal heart rhythms. Headquartered in Las Vegas, Nevada, the company operates internationally through various subsidiaries and is actively expanding its footprint in markets such as China and Canada. Cardiac Biotech Solutions aims to provide more accurate and accessible cardiac data for patients at risk of arrhythmias outside of traditional clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiac Biotech Solutions.